BAFNA PHARMACEUTICALS
Back to Income Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹152 Cr | ₹115 Cr | ₹85 Cr | ₹71 Cr | ₹42 Cr |
What is the latest Revenue of BAFNA PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹152 Cr |
| Mar2024 | ₹115 Cr |
| Mar2023 | ₹85 Cr |
| Mar2022 | ₹71 Cr |
| Mar2021 | ₹42 Cr |
How is Revenue of BAFNA PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹152 Cr | 32.18 | |
| Mar2024 | ₹115 Cr | 35.48 | |
| Mar2023 | ₹85 Cr | 19.55 | |
| Mar2022 | ₹71 Cr | 67.68 | |
| Mar2021 | ₹42 Cr | - | |
Compare Revenue of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹289.5 Cr | -8.2% | -17.5% | 60.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -8.2% |
-17.5% |
60.6% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses